论文部分内容阅读
目的:评价布地奈德与沙丁胺醇联用雾化吸入对小儿喘息样支气管炎患者的临床疗效。方法:选取2013年1月—2014年12月间收治的小儿喘息样支气管炎患者83例为研究对象,依据治疗方法的不同将其分为治疗组(46例)与对照组(37例);两组患者均给予抗病毒、吸氧、补液、镇静、抗炎、能量合剂以及维持酸碱平衡等基础治疗,对照组患者在此基础治疗上加用布地奈德雾化吸入治疗,治疗组患者在对照组基础上再给予沙丁胺醇雾化吸入治疗,连续治疗7 d后比较两组患者的总有效率、住院时间以及临床症状体征消失时间。结果:治疗组患者治疗后的总有效率为93.48%明显优于对照组为78.38%(P<0.05);发热消退时间、咳嗽消失时间、肺部哮鸣音消失时间、喘憋消失时间以及住院时间均优于对照组(P<0.05)。结论:采用布地奈德与沙丁胺醇联用雾化吸入治疗优于布地奈德雾化吸入治疗。
Objective: To evaluate the clinical efficacy of budesonide combined with salbutamol inhalation on asthmatic bronchitis in children. Methods: A total of 83 children with asthmatic bronchitis treated in our hospital from January 2013 to December 2014 were selected as study subjects. According to the different treatment methods, they were divided into treatment group (46 cases) and control group (37 cases). Both groups were given basic treatment of antivirus, oxygen inhalation, fluid replacement, sedation, anti-inflammatory, energy mixture and maintenance of acid-base balance. Patients in the control group received budesonide inhalation therapy on the basis of this treatment. On the basis of the control group, salbutamol inhalation was given. After 7 days of continuous treatment, the total effective rate, length of hospital stay, and disappearance of clinical symptoms and signs were compared. Results: The total effective rate of the treatment group was 93.48%, which was significantly better than that of the control group (78.38%) (P <0.05). The fever subsided time, the cough disappearing time, the disappearance time of the lung wheeze, the disappearance time of asthma, Time were better than the control group (P <0.05). Conclusion: Budesonide and salbutamol combined with inhalation therapy is superior to budesonide inhalation therapy.